Trastuzumab May Improve Survival in Women with Rare Endometrial Cancer

For some women with HER2-positive uterine serous carcinoma, a rare type of endometrial cancer, treating them with trastuzumab (Herceptin) and chemotherapy may help them live longer, according to updated results from a small clinical trial.

from Cancer Currents: An NCI Cancer Research Blog https://ift.tt/3gUWtPS